CXCL10 and COVID-19: Higher neutralizing activity in participants with the OP pattern, rather than a stronger innate immune response (IFN-α and CXCL10), is considered to be consistent with the better prognosis of OP because an earlier humoral immune response has previously been linked to a better prognosis of COVID-19 [34,35].